NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ·Healthcare·Biotechnology
$1.50
+7.53%
Mkt Cap $11.22M
No analyst coverage available
We don't have analyst ratings or price target data for NeuroSense Therapeutics Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.